about
Description of Patients Undergoing Mohs Surgery in Spain: Initial Report on Data From the Spanish Registry of Mohs Surgery (REGESMOHS).Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm Registry.[Medical-cosmetic devices for home use: Present and future considerations][Treatment of mucosal vascular malformations with variable-pulse neodymium:yttrium-aluminum-garnet laser].European evidence-based (S3) guidelines for the treatment of acne.Genetic analysis of the GRM1 gene in human melanoma susceptibility.Polymorphisms Associated with Age at Onset in Patients with Moderate-to-Severe Plaque Psoriasis.Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate-to-severe plaque psoriasis: data from the Spanish Biologics Registry, Biobadaderm.Lichen sclerosus and squamous cell carcinoma.Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: on efficacy and choice of treatment. Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology.Characterization of Surgical Procedures in the Spanish Mohs Surgery Registry (REGESMOHS) for 2013-2015.Clinical Management of Psoriatic Arthritis in Spain: The CALIPSO Study.Points to Consider in the Foundation of Multidisciplinary Units for Psoriatic Arthritis: A Delphi Study and a Systematic Review of the Literature.Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry.Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis.Muckle-Wells Syndrome: A Case Report with an NLRP3 T348M Mutation.Dermoscopic features of melanocytic nevi in seven different anatomical locations in patients with atypical nevi syndrome.Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry.Human papilloma virus dermatosis in human immunodeficiency virus-positive patients: A 14-year retrospective study in 965 patients.Sexually transmitted infections in a cohort of HIV-positive patients.Combined in vivo reflectance confocal microscopy and digital dermoscopy for follow up of patients at high risk of malignant melanoma: A prospective case series study.A consensus-based practical and daily guide for the treatment of acne patients.Febrile ulceronecrotic Mucha-Habermann disease.Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over time.Genome-Wide Pathway Analysis Identifies Genetic Pathways Associated with Psoriasis.Effect of a family history of psoriasis and age on comorbidities and quality of life in patients with moderate to severe psoriasis: Results from the ARIZONA study.[Sentinel lymph node biopsy in melanoma: our experience over 8 years in a universitary hospital].A deletion at ADAMTS9-MAGI1 locus is associated with psoriatic arthritis risk.Long lasting interstitial generalized granuloma annulare on sun-exposed areas.Usefulness of confocal microscopy in distinguishing between basal cell carcinoma and intradermal melanocytic nevus on the face.Twice-daily versus once-daily applications of pimecrolimus cream 1% for the prevention of disease relapse in pediatric patients with atopic dermatitis.Cutaneous diffuse large B-cell lymphoma, leg type, secondary to testicular diffuse large B-cell lymphoma.Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry.A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris.Lipoblastoma in an 8-year-old child: an atypical presentation of a rare tumor.Herpes zoster in children vaccinated against varicella-zoster virus: experience in our hospital.PRACTICAL MANAGEMENT OF ACNE FOR CLINICIANS An International Consensus from the Global Alliance to Improve Outcomes in Acne.Rapidly involuting congenital hemangioma associated with transient anemia and thrombocytopenia.Systemic contact dermatitis due to amethocaine following digital rectal examination.Mohs micrographic surgery in the elderly: comparison of tumours, surgery and first-year follow-up in patients younger and older than 80 years old in REGESMOHS.
P50
Q30961965-10957488-32CA-4AFE-9664-6D8B0805B2FFQ31132539-0C355390-421B-497A-89BE-E88B552BC1B6Q33557978-E3EF5C5A-0442-4EBB-BCAA-9413AA086B42Q33906383-AB54952A-8A46-401A-AE2D-75A49B496E25Q34636056-8687CD10-B181-420A-A914-05F36F1DD90EQ34645746-E198BF2F-CD7F-467D-96DE-425A210B2F8FQ36285391-5DEA6652-3CE6-402B-9BA8-28B1084D4407Q36366753-FBE375DC-4ED6-48FF-BB86-FC0032D5E5FAQ37996735-E3D6641B-CE89-4D46-B8C7-C40EE278085AQ38135652-CC3AD926-8C6D-4B80-8B39-546C197DF062Q38627677-3F4F33E3-05CE-4F5C-8BC3-867B25619492Q38678535-2317B2A3-1B23-4C82-BE2F-EABAE75D59CAQ38809161-8BC8DE2E-18BC-4056-8C6C-AB7AB2E4BC14Q39345624-BDF2BAB8-D8E4-4896-8C84-DD1FE700FE50Q39665899-49E1BAB4-8782-463B-A9EF-E337A22111B7Q40096044-F27D123B-C7D6-400E-A9DD-01F171E08597Q40096066-AF4D79A0-C971-42C7-AF28-FA17BED9DB1EQ40311189-C2A10856-3622-45D3-B854-96F196CAC254Q40317300-3B0F553E-16F2-46CF-B940-4FB49AB2C32CQ40389504-0C89E81C-C88C-43AD-B7A0-54D391455586Q40443305-4582C3CD-E00B-4A78-B0F8-5C7B6F568F6CQ40675163-6FBE783D-7A75-45BE-A0B1-9F152B25C409Q40710225-7C847DA0-FBAA-4262-B218-E12915951D26Q40770468-9A90042E-55BE-43C0-872C-1B4B452DE044Q40992479-0AB059BB-7C11-48FA-A106-889684FECA5BQ41230071-A7A8FB55-2B63-4872-83A0-CE35843CB717Q41614654-82CC5B95-E161-4267-B51A-09ECEA2B06C3Q41728348-DE0B10A4-62B8-4E19-8BD2-B48C2E6E85BDQ41928278-96EADAA7-A72F-4793-B460-AF741DF6527DQ42478621-25D38E83-350E-42EF-9BBD-CE1C8A21952DQ43258879-DC489B43-9377-4E39-A509-4F067234B87FQ43957748-4A170335-3CC6-4A2B-B164-5626B404D292Q44377041-B773CFF8-247A-4DAE-9489-015DC5F081DBQ44941988-71B29B27-B72E-4818-B87D-D72F955D7C4FQ44978760-F70A9569-2A10-4C62-AE8D-57CF397E7581Q45344009-FE353220-F3F8-4775-85F9-ACFCA0D7C460Q46315917-1FF3B033-FB51-4273-BF2B-F446EF082E8FQ46620836-120C0B01-51F7-47FF-A51E-C7001B52AA22Q47661633-E2B9749E-DABB-40B8-8D37-B68A0A536B2CQ47996922-F9C8BA13-365D-425C-9E46-3E2A5D3359C3
P50
description
researcher ORCID ID = 0000-0002-8816-1989
@en
name
José Luis López Estebaranz
@ast
José Luis López Estebaranz
@en
José Luis López Estebaranz
@nl
type
label
José Luis López Estebaranz
@ast
José Luis López Estebaranz
@en
José Luis López Estebaranz
@nl
prefLabel
José Luis López Estebaranz
@ast
José Luis López Estebaranz
@en
José Luis López Estebaranz
@nl
P21
P31
P496
0000-0002-8816-1989